Vyome Holdings, Inc. (NASDAQ:HIND) Short Interest Update

Vyome Holdings, Inc. (NASDAQ:HIND) was the target of a large decline in short interest during the month of June. As of June 30th, there was short interest totaling 35,140 shares, a decline of 45.9% from the June 15th total of 64,989 shares. Based on an average daily volume of 20,610 shares, the short-interest ratio is presently 1.7 days. Approximately 0.7% of the company’s stock are short sold.

Vyome Price Performance

Vyome stock opened at $2.18 on Wednesday. Vyome has a fifty-two week low of $1.75 and a fifty-two week high of $18.60. The firm has a fifty day moving average price of $2.17 and a two-hundred day moving average price of $2.48. The firm has a market cap of $15.30 million, a price-to-earnings ratio of -0.18 and a beta of 1.49.

Vyome (NASDAQ:HIND) last issued its quarterly earnings results on Tuesday, May 12th. The company reported ($0.15) earnings per share (EPS) for the quarter. The firm had revenue of $0.03 million during the quarter. As a group, sell-side analysts expect that Vyome will post -0.6 earnings per share for the current year.

Wall Street Analyst Weigh In

HIND has been the subject of a number of analyst reports. Litchfield Hills Research began coverage on Vyome in a research report on Monday, May 4th. They issued a “buy” rating for the company. Zacks Research raised Vyome to a “hold” rating in a report on Wednesday, May 6th. Finally, Weiss Ratings raised Vyome from a “sell (e)” rating to a “sell (e+)” rating in a research note on Friday, May 1st. Three equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $15.00.

Institutional Inflows and Outflows

An institutional investor recently bought a new stake in Vyome stock. Millennium Management LLC acquired a new stake in shares of Vyome Holdings, Inc. (NASDAQ:HIND) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 45,144 shares of the company’s stock, valued at approximately $155,000. Millennium Management LLC owned about 0.80% of Vyome as of its most recent filing with the Securities & Exchange Commission. Institutional investors and hedge funds own 22.06% of the company’s stock.

About Vyome

ReShape Lifesciences Inc, a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company’s product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract.